![Evaggelos Karavas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Evaggelos Karavas
Direttore Tecnico/Scientifico/R&S presso Pharmathen Pharmaceuticals SA
Posizioni attive di Evaggelos Karavas
Società | Posizione | Inizio | Fine |
---|---|---|---|
Pharmathen Pharmaceuticals SA
![]() Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Direttore/Membro del Consiglio | - | - |
Direttore Tecnico/Scientifico/R&S | - | - | |
Pharmathen International SA
![]() Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Direttore/Membro del Consiglio | 01/01/1991 | - |
Direttore Tecnico/Scientifico/R&S | 01/01/1991 | - | |
Pharmathen SA
![]() Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Direttore Tecnico/Scientifico/R&S | - | - |
Direttore/Membro del Consiglio | 01/01/1991 | - | |
Corporate Officer/Principal | 01/01/2003 | - |
Storia della carriera di Evaggelos Karavas
Formazione di Evaggelos Karavas
Aristotle University of Thessaloniki | Doctorate Degree |
Statistiche
Distribuzione geografica
Grecia | 4 |
Paesi Bassi | 2 |
Posizioni
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Pharmathen Pharmaceuticals SA
![]() Pharmathen Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece. | Health Technology |
Pharmathen International SA
![]() Pharmathen International SA Pharmaceuticals: MajorHealth Technology Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada. | Health Technology |
Pharmathen SA
![]() Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Health Technology |
- Borsa valori
- Insiders
- Evaggelos Karavas
- Esperienza